When Dr Ludlam became director in 1980, his approach to treatment was the following: First, he not only made primary treatment from Haemophilia A became Factor 8 concentrate, but also increased the use of factor concentrates as a whole. Second, he increased the number of patients using home treatment. Read more about When Dr Ludlam became director in 1980, his approach to treatment was the following: First, he not only made primary treatment from Haemophilia A became Factor 8 concentrate, but also increased the use of factor concentrates as a whole. Second, he increased the number of patients using home treatment.
During the 1970s, at the Edinburgh Royal Infirmary, the preferred choice of treatment of Dr Howard Davies was cryoprecipitate, with no commercial concentrates being used. Read more about During the 1970s, at the Edinburgh Royal Infirmary, the preferred choice of treatment of Dr Howard Davies was cryoprecipitate, with no commercial concentrates being used.
The geographical area of the Royal Edinburgh Infirmary covered patients in the south of Fife, Kirkcaldy, Dunfermline and most of the Borders. Read more about The geographical area of the Royal Edinburgh Infirmary covered patients in the south of Fife, Kirkcaldy, Dunfermline and most of the Borders.
During the time that Professor Ludlam was working in Cardiff, he recalled Professor Bloom speaking about the Bournemouth hepatitis outbreak of 1974, making the Cardiff director cautious about US concentrates. Read more about During the time that Professor Ludlam was working in Cardiff, he recalled Professor Bloom speaking about the Bournemouth hepatitis outbreak of 1974, making the Cardiff director cautious about US concentrates.
In relation to the risks of hepatitis, Professor Bloom described to another clinician that a small percentage of these freeze dried preparations contained unavoidably the virus of serum hepatitis and therefore were potentially dangerous to the patient and their relatives. Read more about In relation to the risks of hepatitis, Professor Bloom described to another clinician that a small percentage of these freeze dried preparations contained unavoidably the virus of serum hepatitis and therefore were potentially dangerous to the patient and their relatives.
Annual return from 1979 showing that significant cryoprecipitate were still in use in the Cardiff Haemophilia Centre, but that over a million units of commercial concentrate was in use, compared with 328,538 units of NHS concentrate. Read more about Annual return from 1979 showing that significant cryoprecipitate were still in use in the Cardiff Haemophilia Centre, but that over a million units of commercial concentrate was in use, compared with 328,538 units of NHS concentrate.
Annual return regarding Cardiff Haemophilia Centre from 1978 showing that cryoprecipitate was used twice as much as commercial concentrate. Factorate was the largest in volume as well as substantial quantities of Koate and Hemofil also used. Read more about Annual return regarding Cardiff Haemophilia Centre from 1978 showing that cryoprecipitate was used twice as much as commercial concentrate. Factorate was the largest in volume as well as substantial quantities of Koate and Hemofil also used.
Annual return from 1977 showing that cryoprecipitate was used twice as much as commercial concentrate (primarily Hemofil) than NHS concentrate was used in Cardiff. Read more about Annual return from 1977 showing that cryoprecipitate was used twice as much as commercial concentrate (primarily Hemofil) than NHS concentrate was used in Cardiff.
Annual return from 1976 displaying the results of the treatment of Haemophilia A in Cardiff through the use of substantial quantities of cryoprecipitate, very modest amount of NHS concentrate, significant amounts of Kryobulin and Hemofil, as well as the use of small amounts of Factorate, Profilate and Koate. Read more about Annual return from 1976 displaying the results of the treatment of Haemophilia A in Cardiff through the use of substantial quantities of cryoprecipitate, very modest amount of NHS concentrate, significant amounts of Kryobulin and Hemofil, as well as the use of small amounts of Factorate, Profilate and Koate.
When considering Factor 8 supply, Professor Bloom had stopped using Armor product due to the hepatitis problem and he also no longer bought Immuno because the price was too high. Read more about When considering Factor 8 supply, Professor Bloom had stopped using Armor product due to the hepatitis problem and he also no longer bought Immuno because the price was too high.